Generic marker of inflammation, such as complete blood count (CBC), C reactive protein (CRP) and Eritrocyte Sedimentation Rate (ESR) were widely used in the past for management of IBD patients [125], despite their low sensitivity and specificity [126]. The gene discussed is CRP; the disease is inflammatory bowel disease.